Focus (Forum & Focus)
Apr. 4, 2008
Import Alert: U.S. Needs Strict Oversight of Foreign-Made Drugs
Forum Column - By Bryan A. Liang - The recent heparin case illustrates the dangers that foreign-made drugs pose to American citizens and highlights the need for strict regulatory oversight.
By Bryan A. Liang
This article appears on Page 6
After weeks of investigation, at least 19 deaths, hundreds of adverse drug reactions and recalls by six countries, the foreign material in the Chinese-sourced heparin product has been identified by the FDA as oversulfated chondroitin sulfate, a synthetic material that mimics the activity of real heparin but has no medical value. This counter...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In